Project Grant HT94252510598
Award Date
6/15/25
Completion Date
6/14/29
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
This $1,004,472.00 Project Grant was awarded on June 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports Yale University in conducting advanced biomedical research on mast cell therapy for ovarian cancer. The research aims to transform healthcare for military service members and the broader public by developing innovative approaches to disease prevention, diagnosis, treatment, and management of...
The Department of the Army Medical Command awarded Yale University a $1,304,470.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on July 1, 2025, supports the "DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER" over a performance period ending on June 30, 2029. This research project aims to develop a novel class of universal cellular immunotherapies for the...
The federal Project Grant award in the amount of $705,038.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the "DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER" at Yale University over the period of July 1, 2025 to June 30, 2029. This research project aims to develop innovative cellular immunotherapies for the treatment of ovarian cancer, a...
The Department of the Army Medical Command awarded Yale University a $1,004,997 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund Yale University's pilot development of new forms of chimeric antigen receptor therapies for kidney cancer from August 15, 2021 to August 14, 2024. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Yale University was awarded a $753,749 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2022 through March 2025 to target replication stress in triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Yale University was awarded a $1,244,745 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 to June 2025 to overcome resistance to EGFR inhibitors in advanced head and neck cancers. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award will further...
This $460,279 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Yale University to investigate the "Loss of Proteostasis and Vascular Amyloidosis". The research, conducted from February 2025 to February 2027, aims to transform healthcare for military service members and the general public through innovative and impactful research. Yale University is a...
This Project Grant award from the Defense Health Agency, through the Military Medical Research and Development program (CFDA 12.420), provides $514,335 to Yale University to optimize adoptive cellular immunotherapy for rare melanomas. The award began on September 1, 2023 and is scheduled for completion on August 31, 2026. The research aims to transform health care for service members and the American public through innovative and impactful medical solutions, with a focus on developing treatments...
This federal Project Grant award of $1,009,054 from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) supports research to discover and therapeutically target endogenous retroviruses in clear cell renal cell carcinoma. The award recipient is Yale University, a private research university with expertise in medical research, healthcare, and technology development. The performance period is from September 1, 2025 to August 31, 2029. This grant is...
This $859,773 federal Project Grant was awarded on May 1, 2025 by the Defense Health Agency to Yale University under the Military Medical Research and Development (CFDA 12.420) program. The funding will support a 3-year research project focused on investigating biomarkers and targets related to the progression of leptomeningeal disease from non-small cell lung cancer brain metastasis. The award enables Yale University to conduct advanced biomedical research that aims to transform healthcare...